The Efficacy and Safety of Cettum for Perennial Allergic Rhinitis

Inclusion Criteria: 1. 19 to 60 years-old 2. Presence of nasal symptoms more than 2 consecutive years 3. Presence of two or more nasal symptoms (rhinorrhea, nasal congestion, nasal itching, and sneezing) with severity score ≥ 2 (0 = no symptoms, 1 = mild symptom(s), 2 = moderate symptom(s), and 3 = severe symptom(s)) 4. Positive reaction to the one or more perennial allergen in skin prick test 5. Not having a problem with expression of opinion 6. Willingness to participate in this trial and to sign the informed consent agreement Exclusion Criteria: 1. Treatment with nasal/oral corticosteroids within the past month; herbal medication for rhinitis within the past month; nasal cromolyn or tricyclic antidepressants within the past two weeks; nasal/oral decongestants, nasal/oral antihistamines, or antileukotrienes within the past week 2. Presence of rhinosinusitis (paranasal sinus X-ray demonstrating mucosal thickening or opacification of the paranasal sinuses) 3. Presence of neoplasm, severe systemic inflammation, or other systemic disease that affects rhinitis 4. History of anaphylaxis for allergic tests 5. Females who is pregnant or lactating 6. Being difficult to maintain treatment (e.g. paralysis, severe physical or psychiatric disorder, dementia, drug intoxication, severe visual or hearing impairment) 7. Being afraid of moxibustion treatment or expected adverse effects 8. When the investigators determine that it is inappropriate for participation